Xu R - Search Results

1

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.

Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Among authors: xu r. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.

2

Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.

Qin S, Chen Z, Fang W, Ren Z, Xu R, Ryoo BY, Meng Z, Bai Y, Chen X, Liu X, Xiao J, Ho GF, Mao Y, Wang X, Ying J, Li J, Zhong W, Zhou Y, Siegel AB, Hao C. Qin S, et al. Among authors: xu r. J Clin Oncol. 2023 Mar 1;41(7):1434-1443. doi: 10.1200/JCO.22.00620. Epub 2022 Dec 1. J Clin Oncol. 2023. PMID: 36455168 Free PMC article. Clinical Trial.

3

m⁶A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.

Zhang C, Ou S, Zhou Y, Liu P, Zhang P, Li Z, Xu R, Li Y. Zhang C, et al. Among authors: xu r. Front Oncol. 2021 Aug 11;11:696371. doi: 10.3389/fonc.2021.696371. eCollection 2021. Front Oncol. 2021. PMID: 34458141 Free PMC article.

4

Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.

Xu RC, Liu HC, Li JL, Li K, Ou SY, Yu ZY, Kong Y, Ma GA, Shao WS. Xu RC, et al. Curr Med Res Opin. 2015 Aug;31(8):1553-60. doi: 10.1185/03007995.2015.1058249. Epub 2015 Jul 9. Curr Med Res Opin. 2015. PMID: 26067770

5

Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study.

Ou S, Xu R, Li K, Chen Y, Kong Y, Liu H, Li J, Ouyang Y, Yu X. Ou S, et al. Among authors: xu r. Cancer Manag Res. 2018 Oct 31;10:5227-5237. doi: 10.2147/CMAR.S170160. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464620 Free PMC article.

6

Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.

Li J, Yu X, Liu Q, Ou S, Li K, Kong Y, Liu H, Ouyang Y, Xu R. Li J, et al. Among authors: xu r. Mol Med Rep. 2019 May;19(5):4067-4080. doi: 10.3892/mmr.2019.10061. Epub 2019 Mar 19. Mol Med Rep. 2019. PMID: 30896819 Free PMC article.

7

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.

Tak WY, Lin SM, Wang Y, Zheng J, Vecchione A, Park SY, Chen MH, Wong S, Xu R, Peng CY, Chiou YY, Huang GT, Cai J, Abdullah BJJ, Lee JS, Lee JY, Choi JY, Gopez-Cervantes J, Sherman M, Finn RS, Omata M, O'Neal M, Makris L, Borys N, Poon R, Lencioni R. Tak WY, et al. Among authors: xu r. Clin Cancer Res. 2018 Jan 1;24(1):73-83. doi: 10.1158/1078-0432.CCR-16-2433. Epub 2017 Oct 10. Clin Cancer Res. 2018. PMID: 29018051 Clinical Trial.

8

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients.

Zhao Y, Wang WJ, Guan S, Li HL, Xu RC, Wu JB, Liu JS, Li HP, Bai W, Yin ZX, Fan DM, Zhang ZL, Han GH. Zhao Y, et al. Among authors: xu rc. Ann Oncol. 2013 Jul;24(7):1786-1792. doi: 10.1093/annonc/mdt072. Epub 2013 Mar 18. Ann Oncol. 2013. PMID: 23508822 Free article.

9

Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.

Zuo CH, Xia M, Liu JS, Qiu XX, Lei X, Xu RC, Liu HC, Li JL, Li YG, Li QL, Xiao H, Hong Y, Wang XH, Zhu HZ, Wu QF, Burns M, Liu C. Zuo CH, et al. Asian Pac J Cancer Prev. 2015;16(1):245-51. doi: 10.7314/apjcp.2015.16.1.245. Asian Pac J Cancer Prev. 2015. PMID: 25640360 Free article.

10

Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.

Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K. Feng X, et al. Among authors: xu r, xu j. Am J Gastroenterol. 2014 Dec;109(12):1891-9. doi: 10.1038/ajg.2014.343. Epub 2014 Nov 18. Am J Gastroenterol. 2014. PMID: 25403366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,415 results

Search Page